Clinical Trial Update: An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres

View source ↗

Summary

A Bayer-sponsored completed observational cross-sectional study evaluating sociodemographic and clinical characteristics of patients with nonvalvular atrial fib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Snippet

Sponsor: Bayer | Conditions: Stroke, Prevention and Control | Status: COMPLETED